CNCR vs. VHT

Last updated Jun 24, 2026

CNCR (Loncar Cancer Immunotherapy ETF) and VHT (Vanguard Health Care ETF) are both Health & Biotech Equities funds - CNCR tracks the Loncar Cancer Immunotherapy Index while VHT tracks the MSCI US Investable Market Health Care 25/50 Index. Both are passively managed. CNCR charges 0.79%/yr vs 0.09%/yr for VHT.

Performance

CNCR vs. VHT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Loncar Cancer Immunotherapy ETF (CNCR) and Vanguard Health Care ETF (VHT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

VHT

• 1D: 1.30%
• 1M: 2.66%
• YTD: -0.03%
• 6M: -0.44%
• 1Y: 19.32%
• 3Y*: 7.09%
• 5Y*: 4.60%
• 10Y*: 10.14%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CNCR vs. VHT - Yearly Performance Comparison

	2026 (YTD)
CNCR Loncar Cancer Immunotherapy ETF	0.00%
VHT Vanguard Health Care ETF	0.64%

CNCR vs. VHT - Sectors Allocation Comparison

Sectors	CNCR	VHT
Healthcare	96.6%	100.0%
Financial Services	3.3%	0.0%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Industrials	-	0.0%
Real Estate	-	-
Technology	-	0.0%
Utilities	-	-

Return for Risk

CNCR vs. VHT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CNCR

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

VHT

VHT Risk / Return Rank: 37
VHT Sharpe Ratio Rank: 39
VHT Sortino Ratio Rank: 42
VHT Omega Ratio Rank: 36
VHT Calmar Ratio Rank: 39
VHT Martin Ratio Rank: 32

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CNCR vs. VHT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Loncar Cancer Immunotherapy ETF (CNCR) and Vanguard Health Care ETF (VHT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CNCR	VHT	Difference
Sharpe ratio: Return per unit of total volatility	—	1.32	—
Sortino ratio: Return per unit of downside risk	—	2.04	—
Omega ratio: Gain probability vs. loss probability	—	1.23	—
Calmar ratio: Return relative to maximum drawdown	—	1.87	—
Martin ratio: Return relative to average drawdown	—	4.59	—

Drawdowns

CNCR vs. VHT - Drawdown Comparison

The maximum CNCR drawdown since its inception was 0.00%, smaller than the maximum VHT drawdown of -39.12%. Use the drawdown chart below to compare losses from any high point for CNCR and VHT.

Drawdown Indicators

	CNCR	VHT	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	-39.12%	+39.12%
Max Drawdown (1Y) Largest decline over 1 year	—	-10.40%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-16.91%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-17.71%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-28.85%	—
Current Drawdown Current decline from peak	0.00%	-3.20%	+3.20%
Average Drawdown Average peak-to-trough decline	0.00%	-5.98%	+5.98%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	4.22%	—

Volatility

Volatility by Period

	CNCR	VHT	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	5.02%	—
Volatility (6M) Calculated over the trailing 6-month period	—	10.49%	—
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	14.72%	-14.72%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	15.03%	-15.03%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	16.95%	-16.95%

CNCR vs. VHT - Expense Ratio Comparison

CNCR has a 0.79% expense ratio, which is higher than VHT's 0.09% expense ratio.

Dividends

CNCR vs. VHT - Dividend Comparison

CNCR has not paid dividends to shareholders, while VHT's dividend yield for the trailing twelve months is around 1.64%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
VHT Vanguard Health Care ETF	1.64%	1.61%	1.53%	1.36%	1.33%	1.14%	1.21%	1.89%	1.38%	1.31%	1.45%	1.22%

Frequently Asked Questions

Which ETF is better, CNCR or VHT?

On fees, VHT is cheaper at 0.09% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, CNCR or VHT?

VHT is cheaper with a 0.09% expense ratio, compared with 0.79% for CNCR.

Which ETF pays a higher dividend yield, CNCR or VHT?

VHT has the higher dividend yield at 1.64%, compared with 0.00% for CNCR.

What is the main difference between CNCR and VHT?

CNCR tracks Loncar Cancer Immunotherapy Index, while VHT tracks MSCI US Investable Market Health Care 25/50 Index. They also come from different issuers: Exchange Traded Concepts and Vanguard. Their fees differ too: 0.79% for CNCR and 0.09% for VHT.